Drugs / BHA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03826784 | Nov 2019 → Jan 2022 | — | Carmell Therapeutics Corporation | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BHA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03826784 ↗ |
| Route | Other | “applied directly to the bone fracture” NCT03826784 ↗ |